Impact of a 2-year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetes.

Published on Dec 8, 2020in Cardiovascular Diabetology7.332
· DOI :10.1186/S12933-020-01178-2
Shaminie J. Athinarayanan7
Estimated H-index: 7
 , Sarah Hallberg5
Estimated H-index: 5
 (IU: Indiana University)+ 6 AuthorsRonald M. Krauss138
Estimated H-index: 138
 (UCSF: University of California, San Francisco)
Sources
Abstract
BACKGROUND We have previously reported that in patients with type 2 diabetes (T2D) consumption of a very low carbohydrate diet capable of inducing nutritional ketosis over 2 years (continuous care intervention, CCI) resulted in improved body weight, glycemic control, and multiple risk factors for cardiovascular disease (CVD) with the exception of an increase in low density lipoprotein cholesterol (LDL-C). In the present study, we report the impact of this intervention on markers of risk for atherosclerotic cardiovascular disease (CVD), with a focus on lipoprotein subfraction particle concentrations as well as carotid-artery intima-media thickness (CIMT). METHODS Analyses were performed in patients with T2D who completed 2 years of this study (CCI; n = 194; usual care (UC): n = 68). Lipoprotein subfraction particle concentrations were measured by ion mobility at baseline, 1, and 2 years and CIMT was measured at baseline and 2 years. Principal component analysis (PCA) was used to assess changes in independent clusters of lipoprotein particles. RESULTS At 2 years, CCI resulted in a 23% decrease of small LDL IIIb and a 29% increase of large LDL I with no change in total LDL particle concentration or ApoB. The change in proportion of smaller and larger LDL was reflected by reversal of the small LDL subclass phenotype B in a high proportion of CCI participants (48.1%) and a shift in the principal component (PC) representing the atherogenic lipoprotein phenotype characteristic of T2D from a major to a secondary component of the total variance. The increase in LDL-C in the CCI group was mainly attributed to larger cholesterol-enriched LDL particles. CIMT showed no change in either the CCI or UC group. CONCLUSION Consumption of a very low carbohydrate diet with nutritional ketosis for 2 years in patients with type 2 diabetes lowered levels of small LDL particles that are commonly increased in diabetic dyslipidemia and are a marker for heightened CVD risk. A corresponding increase in concentrations of larger LDL particles was responsible for higher levels of plasma LDL-C. The lack of increase in total LDL particles, ApoB, and in progression of CIMT, provide supporting evidence that this dietary intervention did not adversely affect risk of CVD.
📖 Papers frequently viewed together
20093.86Journal of Clinical Lipidology
15 Authors (Wm. James Howard, ..., Barbara V. Howard)
17 Citations
20180.53International Journal of Diabetes in Developing Countries
3 Authors (J.T. Joseph, ..., Grace George)
20122.71British Journal of Biomedical Science
5 Authors (M. Chu, ..., Christopher W.K. Lam)
24 Citations
References50
Newest
Jun 21, 2020·European Heart Journal22.67
#1Jan Borén (Sahlgrenska University Hospital)H-Index: 90
#2M. John Chapman (NIH: National Institutes of Health)H-Index: 93
Last. Henry N. Ginsberg (Columbia University)H-Index: 118
view all 30 authors...
201 CitationsSource
May 5, 2020·Journal of the American College of Cardiology20.59
#1Edward K. Duran (Brigham and Women's Hospital)H-Index: 1
#2Aaron W. Aday (VUMC: Vanderbilt University Medical Center)H-Index: 11
Last. Aruna D. PradhanH-Index: 45
view all 6 authors...
Abstract Background Elevated triglyceride-rich lipoprotein (TRL) and small-dense low-density lipoprotein (sdLDL) particles are hallmarks of atherogenic dyslipidemia, and their cholesterol content is hypothesized to drive atherosclerotic risk. Prospective epidemiological data pertaining to cholesterol content of TRLs and sdLDL in primary prevention populations are mostly limited to coronary heart disease. Objectives The purpose of this study was to prospectively evaluate whether triglyceride-rich...
27 CitationsSource
Sep 10, 2019·Diabetes Research and Clinical Practice4.23
#1Pouya Saeedi (International Diabetes Federation)H-Index: 12
#2Inga Petersohn (International Diabetes Federation)H-Index: 2
Last. Dominic Bright (Swansea University)H-Index: 2
view all 13 authors...
Abstract Aims To provide global estimates of diabetes prevalence for 2019 and projections for 2030 and 2045. Methods A total of 255 high-quality data sources, published between 1990 and 2018 and representing 138 countries were identified. For countries without high quality in-country data, estimates were extrapolated from similar countries matched by economy, ethnicity, geography and language. Diabetes prevalence (including previously undiagnosed diabetes) in adults aged 20 to 79 years was estim...
1,654 CitationsSource
Aug 26, 2019·International Journal of Environmental Research and Public Health2.85
#1Claudio Tana (University of Parma)H-Index: 19
#2Stefano BallestriH-Index: 29
Last. Tiziana MeschiH-Index: 42
view all 12 authors...
New evidence suggests that non-alcoholic fatty liver disease (NAFLD) has a strong multifaceted relationship with diabetes and metabolic syndrome, and is associated with increased risk of cardiovascular events, regardless of traditional risk factors, such as hypertension, diabetes, dyslipidemia, and obesity. Given the pandemic-level rise of NAFLD—in parallel with the increasing prevalence of obesity and other components of the metabolic syndrome—and its association with poor cardiovascular outcom...
57 CitationsSource
Aug 1, 2019·Diabetes, Obesity and Metabolism5.90
#1Sarah Hallberg (IU: Indiana University)H-Index: 5
#2Nancy E. DockterH-Index: 1
Last. Shaminie J. AthinarayananH-Index: 7
view all 4 authors...
Aims The global rate of type 2 diabetes (T2D) continues to rise. Guidelines that influence the worldwide treatment of this disease are central to changing this trajectory. We sought in this review to evaluate the appropriateness of sources cited in the American Diabetes Association's (ADA) guidelines on eating patterns for T2D management, identify additional relevant sources, and evaluate the evidence. Materials and methods We reviewed the evidence behind the ADA's recommendations on eating patt...
17 CitationsSource
Jul 1, 2019·The American Journal of Clinical Nutrition6.77
#1Nathalie Bergeron (Touro University California)H-Index: 30
#2Sally Chiu (Children's Hospital Oakland Research Institute)H-Index: 17
Last. Ronald M. Krauss (Children's Hospital Oakland Research Institute)H-Index: 138
view all 5 authors...
BACKGROUND: Dietary recommendations to limit red meat are based on observational studies linking intake to cardiovascular disease (CVD) risk together with the potential of its saturated fatty acid (SFA) content to raise low-density lipoprotein (LDL) cholesterol. However, the relation of white meat to CVD risk, and the effects of dietary protein source on lipoprotein particle subfractions, have not been extensively evaluated. OBJECTIVE: We tested whether levels of atherogenic lipids and lipoprote...
37 CitationsSource
Jun 20, 2019·JCI insight6.21
#1Parker N. Hyde (OSU: Ohio State University)H-Index: 8
#2Teryn N. Sapper (OSU: Ohio State University)H-Index: 8
Last. Jeff S. VolekH-Index: 102
view all 17 authors...
BACKGROUNDMetabolic syndrome (MetS) is highly correlated with obesity and cardiovascular risk, but the importance of dietary carbohydrate independent of weight loss in MetS treatment remains controversial. Here, we test the theory that dietary carbohydrate intolerance (i.e., the inability to process carbohydrate in a healthy manner) rather than obesity per se is a fundamental feature of MetS.METHODSIndividuals who were obese with a diagnosis of MetS were fed three 4-week weight-maintenance diets...
71 CitationsSource
Jun 5, 2019·Frontiers in Endocrinology3.64
#1Shaminie J. AthinarayananH-Index: 7
#2Rebecca N. AdamsH-Index: 14
Last. James P. McCarter (WashU: Washington University in St. Louis)H-Index: 35
view all 9 authors...
Purpose: Studies on long-term sustainability of low-carbohydrate approaches to treat diabetes are limited. We previously reported the effectiveness of a novel digitally-monitored continuous care intervention (CCI) including nutritional ketosis in improving weight, glycemic outcomes, lipid, and liver marker changes at 1 year. Here, we assess the effects of the CCI at 2 years. Materials and methods: An open label, non-randomized, controlled study with 262 and 87 participants with T2D were enrolled...
98 CitationsSource
Jan 3, 2019·The New England Journal of Medicine74.70
#1Deepak L. Bhatt (Brigham and Women's Hospital)H-Index: 167
#2P. Gabriel StegH-Index: 79
Last. Reduce-It InvestigatorsH-Index: 4
view all 13 authors...
Abstract Background Patients with elevated triglyceride levels are at increased risk for ischemic events. Icosapent ethyl, a highly purified eicosapentaenoic acid ethyl ester, lowers triglyceride levels, but data are needed to determine its effects on ischemic events. Methods We performed a multicenter, randomized, double-blind, placebo-controlled trial involving patients with established cardiovascular disease or with diabetes and other risk factors, who had been receiving statin therapy and wh...
1,112 CitationsSource
Jan 1, 2019·Methodist DeBakey cardiovascular journal
#1W. Sean Davidson (UC: University of Cincinnati)H-Index: 44
#2Amy S. Shah (University of Cincinnati Academic Health Center)H-Index: 22
: Plasma cholesterol levels of high-density lipoproteins (HDL) have been associated with cardioprotection for decades. However, there is an evolving appreciation that this lipoprotein class is highly heterogeneous with regard to composition and functionality. With the advent of advanced lipid-testing techniques and methods that allow both the quantitation and recovery of individual particle populations, we are beginning to connect the functionality of HDL subspecies with chronic metabolic diseas...
8 CitationsSource
12345
Cited By12
Newest
Sep 23, 2021·Herz1.03
#1N Worm
#2O Weingärtner
Last. Katharina LechnerH-Index: 4
view all 4 authors...
Source
Sep 23, 2021·Herz1.03
#1N Worm
#2O Weingärtner
Last. Katharina LechnerH-Index: 4
view all 4 authors...
Die „Fetthypothese der koronaren Herzkrankheit“, derzufolge „gesattigte Fettsauren“ („saturated fatty acids“, SFA) die LDL(„low-density lipoprotein“)-Cholesterin-Konzentration (LDL-C) steigern und folglich das Risiko fur kardiovaskulare Erkrankungen erhohen, pragte die Ernahrungsempfehlungen der letzten 60 Jahre, zunachst in den USA und spater auch in Europa. Uber die Jahre mehrte sich Evidenz aus Epidemiologie und kontrollierten klinischen Studien, dass der Konsum von SFA per se nicht mit einem...
Source
The last decade has seen nearly 20 papers reviewing the totality of the data on saturated fats and cardiovascular outcomes, which, altogether, have demonstrated a lack of rigorous evidence to support continued recommendations either to limit the consumption of saturated fatty acids or to replace them with polyunsaturated fatty acids. These papers were unfortunately not considered by the process leading to the most recent U.S. Dietary Guidelines for Americans, the country’s national nutrition pol...
Source
Although carbohydrate restriction is not a new approach for the management of Type 2 diabetes, interest in its safety and efficacy has increased significantly in recent years. The purpose of the current narrative review is to summarise the key relevant research and practical considerations in this area, as well as to explore some of the common concerns expressed in relation to the use of such approaches. There is a strong physiological rationale supporting the role of carbohydrate restriction fo...
Source
Jul 14, 2021·Integrative Cancer Therapies2.38
#1Tahj Blow (Cornell University)
#2Parker N. Hyde (University of North Georgia)H-Index: 8
Last. James H. Flory (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 22
view all 12 authors...
Alpelisib is a α-selective phosphatidylinositol 3-kinase (PI3K) inhibitor approved for treatment of postmenopausal women, and men, with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-), PIK3CA-mutated, advanced breast cancer (ABC). Hyperglycemia is a common, on-target adverse effect that impairs treatment efficacy and increases the rate of treatment delays, dose reductions, and discontinuation. Currently, there are no clear guidelines on how to manage hy...
Source
Jun 25, 2021·Saudi Journal of Biological Sciences2.80
#1Karemah A. Alatawi (KAU: King Abdulaziz University)
#2Fawzia A. Alshubaily (KAU: King Abdulaziz University)H-Index: 3
Type 2 diabetes mellitus (T2DM) is a chronic and one of the most common metabolic diseases affecting large proportion of world population. Diabetes-induced changes in lipid and renal parameters are major risk factors contributing to diabetic complications such as diabetic nephropathy and cardiovascular diseases. Due to adverse effects associated with pharmacological intervention in the T2DM treatment, there is an increased interest in the research focussing on identifying novel plant based thera...
Source
May 17, 2021·Nutrients4.55
#1Ahmad H. Alzahrani
#2Mads J. SkytteH-Index: 4
Last. Faidon MagkosH-Index: 57
view all 13 authors...
We previously observed beneficial effects of a carbohydrate-reduced, high-protein (CRHP) diet on cardiovascular risk markers in patients with type 2 diabetes mellitus (T2DM) in a crossover 2 × 6-week trial, when all food was provided to subjects as ready-to-eat meals. Here, we report the results from a 6-month open label extension: 28 patients with T2DM were instructed to self-prepare the CRHP diet with dietetic guidance. At weeks 0, 6, 12, and 36, fasting and postprandial (4-h meal test) blood ...
Source
Apr 13, 2021·Mbio6.78
#1Jonathan Sholl (University of Bordeaux)H-Index: 1
#2Lucy J. MailingH-Index: 6
Last. Thomas R. Wood (Florida Institute for Human and Machine Cognition)H-Index: 11
view all 3 authors...
There is a broad consensus in nutritional-microbiota research that high-fat (HF) diets are harmful to human health, at least in part through their modulation of the gut microbiota. However, various studies also support the inherent flexibility of the human gut and our microbiota's ability to adapt to a variety of food sources, suggesting a more nuanced picture. In this article, we first discuss some problems facing basic translational research and provide a different framework for thinking about...
1 CitationsSource
BACKGROUND The feasibility of measuring β-hydroxybutyrate in ISF using a continuous ketone monitoring (CKM) sensor using a single calibration without further adjustments over 14 days is described. METHODS A CKM sensor was developed using wired enzyme technology with β-hydroxybutyrate dehydrogenase chemistry. In vitro characterization of the sensor was performed in phosphate buffered saline at 37°C. In vivo performance was evaluated in 12 healthy participants on low carbohydrate diets, who wore 3...
5 CitationsSource
Feb 5, 2021·Cardiovascular Diabetology7.33
#1Shaminie J. AthinarayananH-Index: 7
#2Sarah Hallberg (IUPUI: Indiana University – Purdue University Indianapolis)H-Index: 5
Last. Ronald M. Krauss (UCSF: University of California, San Francisco)H-Index: 138
view all 9 authors...
Source
12